Stock Events

Stock Events

Johnson & Johnson 

$222.05
42513
-$2.57-1.14% Today

Statistics

Day High
224.78
Day Low
222
52W High
248.56
52W Low
146.36
Volume
126,530,333
Avg. Volume
-
Mkt Cap
535.12B
P/E Ratio
26.33
Dividend Yield
2.39%
Dividend
5.3

Upcoming

26
MAY
Dividend Ex
Increased
 
9
JUN
Dividend Payment
Increased
 
26
AUG
Dividend Ex
Estimated
 
9
SEP
Dividend Payment
Estimated
 
25
NOV
Dividend Ex
Estimated
 

Dividends

2.39%Dividend Yield
Mar 26
$1.3
Dec 25
$1.3
Sep 25
$1.3
Jun 25
$1.3
Mar 25
$1.24
10Y Growth
5.38%
5Y Growth
4.89%
3Y Growth
4.22%
1Y Growth
3.5%

Earnings

22JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
1.99
2.27
2.56
2.84
Expected EPS
2.838954
Actual EPS
N/A

Financials

28.46%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
188.39BRevenue
53.61BNet Income

Analyst Ratings

249.2Average Price Target
The highest estimate is 280.00.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
60%
Hold
40%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap277.02B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap279.67B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap178B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

There is no Profile data available for JNJ.SG.
Show more...
CEO
Mr. Joaquin Duato
Employees
138100
Country
United States
ISIN
US4781601046

Listings

MU
DE
JNJ.MU
F
DE
JNJ.F
SN
CL
JNJ.SN
SA
BR
JNJB34.SA

0 Comments

Share your thoughts

FAQ

What is Johnson & Johnson stock price today?▼
The current price of JNJ is $222.05 USD — it has decreased by -1.14% in the past 24 hours. Watch Johnson & Johnson stock price performance more closely on the chart.
What is Johnson & Johnson stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Johnson & Johnson stocks are traded under the ticker JNJ.
Is Johnson & Johnson stock price growing?▼
JNJ stock has fallen by -3.31% compared to the previous week, the month change is a -6.78% fall, over the last year Johnson & Johnson has showed a +41.28% increase.
What is Johnson & Johnson market cap?▼
Today Johnson & Johnson has the market capitalization of 535.12B
When is the next Johnson & Johnson earnings date?▼
Johnson & Johnson is going to release the next earnings report on July 22, 2026.
What were Johnson & Johnson earnings last quarter?▼
JNJ earnings for the last quarter are 2.7 USD per share, whereas the estimation was 2.68 USD resulting in a +0.85% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Johnson & Johnson revenue for the last year?▼
Johnson & Johnson revenue for the last year amounts to 188.39B USD.
What is Johnson & Johnson net income for the last year?▼
JNJ net income for the last year is 53.61B USD.
Does Johnson & Johnson pay dividends?▼
Yes, JNJ dividends are paid quarterly. The last dividend per share was 1.3 USD. As of today, Dividend Yield (FWD)% is 2.39%.
How many employees does Johnson & Johnson have?▼
As of May 07, 2026, the company has 138,100 employees.
In which sector is Johnson & Johnson located?▼
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?▼
The last stock split for Johnson & Johnson was on June 13, 2001 with a ratio of 2:1.
Where is Johnson & Johnson headquartered?▼
Johnson & Johnson is headquartered in New Brunswick, United States.